Madrigal Pharmaceuticals, Inc. (FRA:YDO1)
Germany flag Germany · Delayed Price · Currency is EUR
363.90
-7.80 (-2.10%)
Last updated: Feb 20, 2026, 7:55 PM CET

Madrigal Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
198.69100.0299.92331.5536.27
Short-Term Investments
784.87826.23534.2227.23234.08
Cash & Short-Term Investments
983.56926.25634.13358.77270.35
Cash Growth
6.19%46.07%76.75%32.71%-4.86%
Accounts Receivable
134.4853.82---
Receivables
134.4853.82---
Inventory
74.8434.07---
Prepaid Expenses
47.813.793.152.61.34
Restricted Cash
5.095---
Total Current Assets
1,2461,033637.28361.37271.68
Property, Plant & Equipment
6.444.593.271.21.65
Other Intangible Assets
7.384.73---
Total Assets
1,2601,042640.55362.57273.33
Accounts Payable
48.8843.628.0423.8321.38
Accrued Expenses
260.39124.789.9891.4655.05
Current Portion of Leases
1.020.980.530.60.41
Total Current Liabilities
310.29169.28118.55115.8976.84
Long-Term Debt
339.88117.57115.4849.29-
Long-Term Leases
6.731.021.19-0.39
Total Liabilities
656.9287.86235.21165.1877.23
Common Stock
00000
Additional Paid-In Capital
2,6922,5561,7411,160863.5
Retained Earnings
-2,090-1,802-1,336-962.66-667.31
Comprehensive Income & Other
0.870.470.47-0.03-0.08
Shareholders' Equity
602.69754.38405.33197.39196.11
Total Liabilities & Equity
1,2601,042640.55362.57273.33
Total Debt
347.63119.57117.1949.890.8
Net Cash (Debt)
635.93806.68516.94308.88269.55
Net Cash Growth
-21.17%56.05%67.36%14.59%-4.88%
Net Cash Per Share
28.3537.9227.6618.0216.30
Filing Date Shares Outstanding
22.9422.0819.918.1417.1
Total Common Shares Outstanding
22.842219.8818.117.1
Working Capital
935.48863.65518.73245.48194.85
Book Value Per Share
26.3934.2820.3910.9011.47
Tangible Book Value
595.31749.65405.33197.39196.11
Tangible Book Value Per Share
26.0634.0720.3910.9011.47
Source: S&P Global Market Intelligence. Standard template. Financial Sources.